Evidence map›Paper›PMID 30873635›Full record

ArticleHepatology (Baltimore, Md.)2019

Spermidine Confers Liver Protection by Enhancing NRF2 Signaling Through a MAP1S-Mediated Noncanonical Mechanism.

Pengfei Liu, Montserrat Rojo de la Vega, Matthew Dodson, Fei Yue, Boyun Shi, Deyu Fang, Eli Chapman, Leyuan Liu, Donna D Zhang

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Reactive Oxygen Species-Mediated TRPM2 Activation Facilitates Phagocytosis of Macrophages to Reverse Profibrotic Phenotype.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Pengfei LiuDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ.
Montserrat Rojo de la VegaDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ.
Matthew DodsonDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ.
Fei YueCenter for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX.
Boyun ShiCenter for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX.
Deyu FangDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Eli ChapmanDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ.
Leyuan LiuCenter for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX.
Donna D ZhangDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ.
University of Arizona · USTexas A&M University · USNorthwestern University · US

Funding

TRANSPORT OF TRACE METALS IN A POLLUTED AQUIFERP42ES004940 · NIEHS · UNIVERSITY OF ARIZONA · PI Jon D Chorover · 1990 to 2026
$68.1M
SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
NRF Transcription Factors in Environmental Stress and Disease InterventionR35ES031575 · NIEHS · UNIVERSITY OF FLORIDA · PI Donna D Zhang · 2020 to 2026
$7.1M
Arsenic, Nrf2 and Autophagy Dysfunction in Type II DiabetesR01DK109555 · NIDDK · UNIVERSITY OF ARIZONA · PI ZHANG, DONNA D · 2016 to 2019
$1.4M
Nrf2, autophagy, and arsenic carcinogenesisR01ES026845 · NIEHS · UNIVERSITY OF ARIZONA · PI ZHANG, DONNA D · 2016 to 2019
$1.4M
NIDDK NIH HHS R01 DK109555NIEHS NIH HHS P30 ES006694NIEHS NIH HHS P42 ES004940NIEHS NIH HHS R01 ES026845NIEHS NIH HHS R35 ES031575NIH HHS P30 ES006694NIH HHS P42 ES004940NIH HHS R01 DK109555NIH HHS R01 ES026845
6 · The paper itself

Abstract

Spermidine (SPD), a naturally occurring polyamine, has been recognized as a caloric restriction mimetic that confers health benefits, presumably by inducing autophagy. Recent studies have reported that oral administration of SPD protects against liver fibrosis and hepatocarcinogenesis through activation of microtubule associated protein 1S (MAP1S)-mediated autophagy. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) is a transcription factor that mediates cellular protection by maintaining the cell's redox, metabolic, and proteostatic balance. In this study, we demonstrate that SPD is a noncanonical NRF2 inducer, and that MAP1S is a component of this noncanonical pathway of NRF2 activation. Mechanistically, MAP1S induces NRF2 signaling through two parallel mechanisms, both resulting in NRF2 stabilization: (1) MAP1S competes with Kelch-like ECH-associated protein 1 (KEAP1) for NRF2 binding through an ETGE motif, and (2) MAP1S accelerates p62-dependent degradation of KEAP1 by the autophagy pathway. We further demonstrate that SPD confers liver protection by enhancing NRF2 signaling. The importance of both NRF2 and p62-dependent autophagy in SPD-mediated liver protection was confirmed using a carbon tetrachloride-induced liver fibrosis model in wild-type, Nrf2

Indexed as

AnimalsAutophagyDrug Evaluation, PreclinicalHEK293 CellsHepatic Stellate CellsHumansKelch-Like ECH-Associated Protein 1LiverLiver CirrhosisMiceMicrotubule-Associated ProteinsNF-E2-Related Factor 2Proto-Oncogene Proteins c-mycSpermidineKeap1 protein, mouseKelch-Like ECH-Associated Protein 1MAP1S protein, mouseMicrotubule-Associated ProteinsNfe2l2 protein, mouseNF-E2-Related Factor 2Proto-Oncogene Proteins c-mycSpermidine

Identifiers

PMID30873635
PMCPMC6597327
OpenAlexW2921710140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.